Objective-The goal of this study was to determine the expression signature and the potential role of microRNAs in human arteries with arteriosclerosis obliterans (ASO). Methods and Results-The expression profiles of microRNAs in human arteries with ASO and in normal control arteries were determined by quantitative reverse transcription-polymerase chain reaction array. Among the 617 detected microRNAs, multiple microRNAs were aberrantly expressed in arteries with ASO. Some of these dysregulated microRNAs were further verified by quantitative reverse transcription-polymerase chain reaction. Among them, microRNA-21 (miR-21) was mainly located in arterial smooth muscle cells (ASMCs) and was increased by more than 7-fold in ASO that was related to hypoxia inducible factor 1-␣. In cultured human ASMCs, cell proliferation and migration were significantly decreased by inhibition of miR-21. 3Ј-Untranslated region luciferase assay confirmed that tropomyosin 1 was a target of miR-21 that was involved in miR-21-mediated cellular effects, such as cell shape modulation. Conclusion-The results suggest that miR-21 is able to regulate ASMC function by targeting tropomyosin 1. The hypoxia inducible factor-1 ␣/miR-21/tropomyosin 1 pathway may play a critical role in the pathogenesis of ASO. These findings might provide a new therapeutic target for human ASO. (Arterioscler Thromb Vasc Biol. 2011;31:
A rteriosclerosis obliterans (ASO) of the lower extremities is a major cause of adult limb loss worldwide. [1] [2] [3] Surgery is still the major approach in the treatment of ASO. However, many patients develop restenosis in 1 year after surgery. 1 It is well established that proliferation and migration of arterial smooth muscle cells (ASMCs) are the major cellular events and the major reasons behind ASO formation and posttreatment restenosis. 4 However, the molecular mechanisms involved in regulation of proliferation and migration of ASMCs in ASO remain unclear.
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MicroRNAs are a novel class of endogenous, small noncoding RNAs that regulate approximately 30% of the encoding genes of the human genome at the posttranscriptional level by binding the 3Ј-untranslated region (UTR) of their target mRNAs. [5] [6] [7] The microRNA expression profile in vessels has recently been described by Ji et al 8 Several microR-NAs, including microRNA-21 (miR-21), miR-221/222, and miR-145, have been found to modulate ASMC function and be involved in the process of artery stenosis in the rat carotid artery balloon injury model. 8 -10 However, the expression profiles of microRNAs in human arteries with ASO are still unknown.
Tissue-specific expression is an important characteristic of microRNA expression. 11 For example, miR-1 is highly expressed in heart, but its expression in artery is low. 8 Such different expression profiles in different tissues suggest that the physiological functions of microRNA in different tissues may be different. 8 Although human ASO and artery stenosis in rat carotid artery injury models share many features, their pathological processes are different. 12, 13 Thus, identifying microRNAs in ASO and clarifying their biological functions would be useful for understanding the mechanisms of ASO formation and searching new therapeutic targets.
In the current study, microRNAs profile in human ASO was determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) array. Some dysregulated microRNAs were further verified by individual qRT-PCR. We found that miR-21 was the most upregulated microRNA in ASO. The potential roles of miR-21 in ASMC functions and ASO, as well as the mechanisms involved, were then investigated.
Methods
The supplemental material, available online at http://atvb. ahajournals.org, provides details of the methods used in this study.
Sample Acquisition
This study was approved by the research ethics committee of the First Affiliated Hospital, Sun Yat-sen University, and informed consent was given by all patients (patients' information detailed in Supplemental Table I ).
MicroRNA qRT-PCR Array
MicroRNA qRT-PCR array was performed in 10 ASO arteries and 3 normal arteries, as previously described. 14
In Situ Hybridization and Immunohistochemistry
In situ hybridization was performed to determine miR-21 localization as described. 8 Immunohistochemistry was performed to determine the localization of smooth muscle (SM) ␣-actin, hypoxia inducible factor (HIF)-1 ␣, and tropomyosin 1 (TPM1). The images acquired were analyzed by calculating integrated optical density (IOD) value.
Cell Culture
Primary human ASMCs (HASMCs) were obtained from femoral artery of a healthy organ donor with the consent of donor and approval of the ethics committee of the First Affiliated Hospital of Sun Yat-sen University.
Northern Blot
Northern blot analysis was performed as described previously. 15
Measurement of ASMC Proliferation, DNA Synthesis, and Cell Cycle Analysis
Cell counting kit-8 and cell counting were performed to detect cell proliferation as described, 16,17 3 H incorporation assay was performed to analyze DNA synthesis as described, 17 and cell cycle analysis was performed using flow cytometry as described. 17
Cell Migration
Transwell assay and wound closure assay were performed as described. 17
Lentiviral Transduction
The lentiviral transduction was performed as previously described. 18 
3-UTR Luciferase Assay
3Ј-UTR luciferase assay was performed to determine direct target genes of miR-21 as described. 19 
Statistics
All data are presented as meanϮSD. The Student t test and 1-way ANOVA with multiple comparisons using the Newman-Keuls test were used for statistical analysis. Relationships between variables were determined by the Pearson correlation coefficient. A probability value of Ͻ0.05 was accepted as statistically significant. All data were processed using GraphPad Prism 5.0 (GraphPad, San Diego, CA) and SPSS software, version 17.0 (SPSS Inc, Chicago, IL).
Results

MicroRNA Expression Profile of Human ASO
Overall, among the 719 arrayed microRNAs, 617 microR-NAs were found in human arteries, including 16 microRNAs that were upregulated more than 1-fold in ASO arteries compared with those in normal arteries. Using qRT-PCR for individual microRNA validation, 9 microRNAs (miR-21, miR-586, miR-2054, miR-518c, miR-140-3p, miR-100, miR-125b, miR-24, and miR-1298) were confirmed as significantly different ( Figure 1A ). In ASO arteries, miR-21 was markedly upregulated to 7.98-fold, whereas 5 microRNAs (miR-140-3p, miR-100, miR-125b, miR-24, miR-1298) were significantly downregulated ( Figure 1A ). MiR-21 is the most upregulated microRNA in ASO arteries and has been reported to regulate proliferation of ASMCs and neointimal formation in rat carotid artery injury model, 8 so we focused on miR-21 to determine its potential biological role in ASO.
MiR-21 Is Highly Expressed in ASO Arteries
To investigate miR-21 distribution in arteries, we prepared 11 normal artery sections and 31 ASO artery sections to represent different artery segments with different extents of lumen loss. The colocalization of miR-21 and SM ␣-actin suggests that miR-21 was localized mainly in ASMCs of ASO ( Figure 1B) . Also, we noticed that miR-21 expression was related to the extent of lumen loss, which might represent the process of atherosclerotic lesions. 20 As described previously, 20, 21 we classified ASO artery sections into 3 categories according to their extent of lumen loss: first, initial pathological thickening with stenosis less than 10%; second, stenosis ranging from 10% to 50%; third, stenosis more than 50%, which is known as significant stenosis. We found that miR-21 expression was upregulated in all ASO sections ( Figure 1C and 1D); however, miR-21 expression was lower in sections with stenosis Ͼ50% compared with the other 2 groups ( Figure 1C and 1E ).
MiR-21 Is Upregulated by Hypoxia Inducible Factor-1␣ Pathway
ASO is considered to be a hypoxic disease, 21 whereas miR-21 is a hypoxia-regulated microRNA. 22 We found that both miR-21 and HIF-1␣ were clearly colocalized in ASMCs (Figure 2A and Supplemental Figure IV ). In cultured ASMCs, HIF-1␣ was increased by platelet-derived growth factor (PDGF)-BB (20 g/L), cobalt chloride (100 mol/L, a chemical hypoxia inducer), and oxidized low-density lipoprotein (75 mg/L) ( Figure 2B and Supplemental Figure IV ). All these reagents have proatherosclerotic effects. 17, 21, 23, 24 Interestingly, a time-course expression of miR-21 was also upregulated by giving these treatments in cultured ASMCs ( Figure 2C ). In contrast, knockdown of HIF-1␣ by small interfering RNAs ( Figure 2D ) decreased miR-21 level significantly in PDGF-BB (20 g/L)-treated ASMCs ( Figure 2E ). Taken together, these data indicate that miR-21 was upregulated by HIF-1␣ in the process of ASO.
MiR-21 Is Essential for HASMC Proliferation and Migration
Although previous studies have shown that miR-21 regulates cell proliferation in both cultured rat ASMCs 8 and many tumor cell lines, 25 it was still unclear whether miR-21 also regulates HASMCs proliferation and migration. Figure 3A and 3B shows that PDGF-BB-stimulated HASMC proliferation was significantly inhibited by the miR-21 inhibitor 2Ј O-methyl (OME)-miR-21. Flow cytometry analysis revealed that inhibition of miR-21 significantly decreased PDGF-BBinduced cell number in S phase. The result suggests that depletion of miR-21 may inhibit PDGF-BB-induced acceleration of cell cycle progression from G 0 /G 1 phase into S phase ( Figure 3D and 3E). This discovery was further confirmed by reduced DNA synthesis ( Figure 3F ). However, we found that 2ЈOME-miR-21 (100 nmol/L) did not increase apoptotic cell numbers in HASMCs cultured with or without serum starvation ( Figure 3C and Supplemental Figure X ). In addition, we found that 2ЈOME-miR-21 significantly decreased PDGF-BB (10 g/L)-induced HASMC migration ( Figure 3G to 3J). The result confirmed that miR-21 might be essential for PDGF-BB-induced HASMCs migration.
TPM1 Is a Direct Target of miR-21
TPM1 was selected as the potential miR-21 target according to its mRNA 3Ј-UTR complementary to miR-21 (predicted by PICTAR-VERT and TARGETSCAN). TPM1 is a vali-dated target of miR-21 in cancer, 26 but it has not been confirmed in vascular cells.
As shown in Figure 4A , miR-21 mimic decreased TPM1 protein. In contrast, TPM1 protein was increased by 2ЈOME-miR-21 ( Figure 4B ). Interestingly, neither miR-21 mimic nor 2ЈOME-miR-21 altered the TPM1 mRNA level ( Figure 4C ). These data indicate that miR-21 negatively regulated TPM1 expression at the posttranscriptional level.
We further determined whether miR-21 could directly bind to the 3Ј-UTR seed sequence of TPM1 mRNA. The 3Ј-UTR sequence of TPM1 containing the putative binding sites of miR-21 were cloned into psiCHECK-2 dual-luciferase vector (Supplemental Figure XI) . The constructed vector was cotransfected with miR-21 mimic or control oligo into HEK293 cells, and an empty vector was used as control. We found that in the presence of the TPM1 3Ј-UTR, miR-21 significantly decreased relative luciferase activity ( Figure  4D ). After miR-21 seed sequence in TPM1 mRNA 3Ј-UTR was mutated (Supplemental Figure XI) , the inhibitory effect of miR-21 on relative luciferase activity was abrogated ( Figure 4E ). Cotransfection of control oligo with vector or empty vector did not alter relative luciferase activity ( Figure  4F ). These results suggest that miR-21 directly bound TPM1 mRNA 3Ј-UTR seed sequence and regulated its expression at posttranscriptional level. Further overexpressing TPM1 decreased ASMC proliferation and migration (Supplemental Figure XII) , whereas silencing TPM1 ( Figure 4G ) significantly attenuated the antiproliferative and antimigratory role of 2ЈOME-miR-21 ( Figure 4H to 4J) . These data indicate that TPM1 was involved in miR-21-induced HASMC proliferation and migration.
MiR-21 Modulates Cell Shape Through Reorganizing Actin-Tropomyosin in HASMCs
In the cardiovascular system, TPM1 constitutes more than 90% of the total translated isoforms of the TPM family. 27 Members of this family take up multiple positions on actin filaments and function as universal regulators of cytoskeleton. 28 -30 Changes of TPMs and actin proportion could induce cytoskeleton reorganization and consequently induce cell shape alteration. 28, 30 As shown in Figure 5A and 5B, miR-21 mimic decreased TPM1 but increased SM ␣-actin, whereas 2ЈOME-miR-21 increased TPM1 but decreased SM ␣-actin. We thus hypothesized that miR-21 might modulate cell shape alteration in HASMCs. With immunocytostaining of TPM1 and SM ␣-actin, cell shape modulation was visualized by confocal microscope and analyzed by calculating cell elongation ratio, which was defined as the length of longest cord through the cell versus the length of longest axis perpendicular to it. 31, 32 As shown in Figure 5C and 5D and Supplemental Figure XIII , HASMCs treated with miR-21 mimic exhibited a high elongation ratio. In contrast, HASMCs treated with 2ЈOME-miR-21 exhibited a low elongation ratio. We found that silencing TPM1 attenuated 2ЈOME-miR-21 induced elongation reduction, whereas overexpressing TPM1 decreased elongation ( Figure 5C and 5D and Supplemental Figure XIII) . These findings indicate that miR-21 was a key regulator in modulating HASMCs cell shape via targeting TPM1. 
MiR-21 Expression Is Negatively Correlated With TPM1 Expression in ASO
Immunohistochemistry analysis demonstrated that TPM1 staining was significantly weaker in ASO artery sections than in normal artery sections ( Figure 6A and 6B) . The TPM1 protein, but not mRNA, was significantly decreased in ASO ( Figure 6C to 6E) . In vitro, miR-21 mimic decreased TPM1 protein expression in a dose-dependent manner in cultured HASMCs ( Figure 6F ). Interestingly, through calculating TPM1 and miR-21 IOD value in 31 pairs of consecutive sections of ASO, we found a negative correlation between the expression of TPM1 and miR-21 in human ASO samples ( Figure 6A and 6G and Supplemental Figure XIV) . These data suggest that upregulation of 
Discussion
In the present study, using a microRNA qRT-PCR array method, we profiled the microRNA expression signature in human ASO samples for the first time. As expected, the microRNA expression profile in ASO arteries is different from that in rat carotid artery injury model, 8 which is consistent with previous findings that tissue-specific or species-specific expression is an important characteristic of microRNA expression. 11 Indeed, although miR-21 was upregulated in both arteries from ASO and the rat carotid artery injury model, miR-146, miR-214, miR-352, and miR-221 upregulation was found only in the rat carotid artery injury model. MiR-125b was downregulated both in arteries from ASO and in the rat carotid artery injury model, but miR-140-3p, miR-100, miR-24, and miR-1298 were downregulated only in arteries from ASO. Such a difference in expression profiles may come from different vessel type or different pathological process between human ASO and rat balloon injury model or may be related to the profiling method. 12, 33 Nevertheless, our findings suggest that identifying mi-croRNA in ASO arteries was necessary and that their biological functions of the microRNAs should be further determined.
Spatial and temporal specificity are the important characteristics of microRNA expression. 34 We first detected the localization of miR-21 in human ASO arteries and found that miR-21 located mainly in ASMCs of artery wall, which was confirmed by real-time polymerase chain reaction (Supplemental Figure III ). This indicates that miR-21 might mainly regulate ASMC function in ASO. MiR-21 was previously found regulating fibrosis 35 and angiogenesis, 36 which also contribute to ASO formation. Our data show that miR-21 colocalized with fibroblasts, as well as angiogenic cells (Supplemental Figure V) , which is worth further study. Furthermore, miR-21 was upregulated mainly in ASO arteries with stenosis less than 50%. The results suggest that miR-21 might be a marker for early stenosis of ASO arteries and regulate other proteins in the initiation of ASO to promote artery stenosis. In addition, a recent study has revealed that miR-130a, miR-27b, and miR-210 could be serum markers for early-stage ASO. 37 Thus, microRNAs may be used a biomarkers for ASO.
Hypoxia has been reported to play key roles in initiating the advanced lesions of ASO by promoting ASMC proliferation and migration, lipid accumulation, increased inflammation, ATP depletion, and angiogenesis. 38 Although there is a lack of evidence that HIF-1␣ directly binds miR-21 promoter, previous studies have shown that miR-21 is regulated by hypoxia 22 and is involved in hypoxia-induced ASMC prolif- eration and migration in pulmonary artery. 39 Here, our findings clearly show that miR-21 was regulated by HIF-1␣. Besides hypoxia, the other 2 key players of atherogenesis, 17, 21, 23, 24, 38 PDGF-BB and oxidized low-density lipoprotein, also stimulated HIF-1␣ expression to induce miR-21 upregulation. These findings suggest that HIF-1␣ upregula-tion to induce miR-21 expression might be a common pathway in the formation of ASO.
It is well established that proliferation and migration of ASMCs play pivotal roles in the process of arteriosclerosis. 4 In the present study, we found that miR-21 was critically involved in PDGF-BB-stimulated HASMC proliferation and migration. However, miR-21 had no antiapoptotic effect on HASMCs, similar to what has been reported in colon cancer cells 40 and HeLa cells 8 but different from findings in rat aortic ASMCs and some tumor cell lines. 8, 41 These findings confirmed that microRNAs have different functions in ASMCs of different arteries or species. 12 One microRNA affects widespread target genes as a result of the flexibility of target-site recognition. 7 Previous studies have demonstrated that PTEN, Bcl-2, and PDCD-4 are critical miR-21 targets in regulating proliferation and apoptosis on ASMCs. 8, 42, 43 TPM1 was selected as a potential miR-21 target according to its seed sequence complementary to miR-21 in mRNA 3Ј-UTR, as well as its participation in cell proliferation and migration. 26 TPM1 was downregulated by miR-21 at posttranscriptional level and was finally validated as a direct target gene of miR-21 by luciferase reporter assay. Moreover, we found that TPM1 was involved in 2ЈOME-miR-21-mediated negative regulation of proliferation on HASMCs.
TPM1 is among the high-molecular-weight members of the TPM family, which are implicated in the formation, stabilization, and regulation of cytoskeletal actin filaments. 28, 44 Reorganization of actin-TPM cytoskeleton alters cell shape and is necessary for cell proliferation and migration. 28, 30, 44 Our findings show that introducing or inhibiting miR-21 altered TPM1 and SM ␣-actin protein proportion and mediated cell shape change by directly targeting TPM1 in HASMCs. However, whether or not cell shape change directly affected ASMC proliferation and migration remains unknown. Previous studies have shown that some microR-NAs, such as miR-21, miR-335, miR-206, miR-138, or miR-24, may affect the cell elongation that is associated with decreased proliferation and invasion in tumor cells. 31, 32, 45, 46 Similarly, in the present study, 2ЈOME-miR-21 mediated cell elongation reduction was associated with the decreased cell proliferation and migration in HASMCs. We postulated that these miR-21-mediated cellular effects might be related to its target TPM1, as TPM1 could stabilize cytoskeleton by decreasing the movement and contraction of actin filaments and make the cells less appropriate for proliferation and migration. 28, 30, 44 Moreover, we found that TPM1 played a key role in 2ЈOME-miR-21-induced antiproliferative and antimigratory effects. In addition, TPM1 also showed an antiapoptotic effect via protecting actin filaments from the severing effects of proapoptotic signals, 28 which may explain why 2ЈOME-miR-21 did not induce HASMCs apoptosis in our study.
Finally, we found a significant decrease of TPM1 protein in ASO samples and a negative correlation between TPM1 and its endogenous inhibitor miR-21 in ASO samples and cultured HASMCs, which suggests that the reduction of TPM1 protein in ASO samples was related to the upregulated miR-21. It has been shown that transcriptional loss of TPM1 in hearts results in cardiomyopathy. 27, 47 Our findings indicate that posttranscriptional loss of TPM1 in arteries may contribute to ASO.
TPM1 expression occurs later than that of SM ␣-actin and smooth muscle myosin heavy chain in smooth muscle cell development, and it has been suggested to be a better phenotypic marker for quiescent smooth muscle cells. 48 In the present study, we found that both TPM1 and SM ␣-actin were abundantly expressed in normal arteries. However, TPM1 protein decreased much more than SM ␣-actin did in ASO arteries, even in arteries with stenosis less than 10%. Such findings suggest that TPM1 might be a better phenotypic marker than SM ␣-actin in assessing quiescent ASMCs.
This study is mainly focusing on elucidating miR-21 function and its underlying mechanisms in human ASO. However, the ethical unavailability of a transgenic/knockout approach in human and the lack of a proper animal model limited validation of miR-21 functions by a genetic approach in ASO.
In summary, microRNAs are aberrantly expressed in ASO samples, and miR-21 is the most upregulated one in ASO samples. Some proatherogenic factors may induce HIF-1␣ to upregulate miR-21 to promote ASMC proliferation and migration through targeting TPM1, which leads to the formation of ASO. Our findings may provide new insight into the mechanisms and critical role of the HIF-1␣/miR-21/TPM1 pathway (Supplemental Figure XV) in the pathogenesis of ASO and provide new targets for preventing and treating ASO.
Sources of Funding
This research was supported by Grant 80000-3211601 from the Universities Scientific-Technological Innovative Team Project of Guangdong Province, China, and by Grant 80000-3126202 from the Yat-sen Innovative Talents Cultivation Program for Excellent Tutors.
